What Sienco does

Sienco, Inc. is a privately held, Boulder, Colorado-based manufacturer of Class II in-vitro diagnostic medical devices focused on point-of-care whole blood coagulation and platelet function testing. The company builds the Sonoclot Analyzer product line around a patented whole blood viscoelastic clot detection mechanism that produces both a qualitative "Sonoclot Signature" graph and quantitative outputs (Activated Clotting Time, Clot Rate, Platelet Function) from a single test, enabling clinical hemostasis management across heparin anticoagulation therapy, hypercoagulation assessment, and bleeding management. Its portfolio comprises three analyzer models (one-channel SC1, one-channel SCP1, and dual-channel SCP2), companion software (SonoView, Signature Viewer), a suite of seven proprietary disposable test kits (kACT, gbACT, gbACT+, H-gbACT+, SonACT, aiACT, Non-Activated), quality control kits, and accessories. Sienco sells direct in the United States and through a network of exclusive and non-exclusive regional distributors internationally, including an exclusive China distribution agreement with Viscell Medical Group (VMG) running through January 31, 2028, and additional distributors in Hong Kong, Japan, Egypt, and the Benelux region. The company's revenue mix combines one-time capital equipment sales (analyzers, software licenses, accessories) with recurring transactions from disposable test kits and quality control consumables, targeting hospitals, operating rooms, coagulation and STAT labs, intensive care units, surgical specialties (cardiovascular, transplant, vascular, orthopedic, obstetrics), and academic research institutions.

Name

Sienco

Legal name

Sienco, Inc.

Website

https://sienco.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Sienco manufactures the Sonoclot Analyzer, a patented point-of-care viscoelastic whole blood coagulation and platelet function monitoring system for hospitals, surgical suites, and research institutions, distributing via US direct sales and an international exclusive and regional distributor network.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostic Medical Devices — Hemostasis Monitoring

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• In-vitro diagnostic devices
• Whole blood coagulation testing
• Platelet function analyzers
• Viscoelastic hemostasis monitoring
• Point-of-care coagulation

Headquarters

HQ city

Boulder

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales - Analyzers: Sienco manufactures and distributes Class II in-vitro diagnostic medical devices including Sonoclot Analyzer instruments (SC1, SCP1, SCP2 models). Revenue from capital equipment sales to hospitals, labs, and clinical facilities.
2. Disposable Test Kits: Recurring revenue from disposable test kits including kACT Kit, gbACT Kit, gbACT+ Kit, H-gbACT+ Kit, SonACT Kit, aiACT Kit, and Non-Activated Clotting Test Kit. Available in various package sizes (24 or 100 tests).
3. Quality Control Products: Quality control kits for analyzers and disposable tests including Reference Viscosity Oil QC Kits and Reference Plasma QC Kit. Monthly quality control supplies generate recurring revenue.
4. Software Licenses: Companion software products including SonoView Data Retrieval Software (SC1) and Signature Viewer Data Collection Software (SCP1/SCP2). Software licenses sold in one-copy units.
5. Accessories: Accessories including SonOil light oil, Probe Extractor forceps, and Blunt Cannula Tips.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Sienco manufactures and distributes the Sonoclot Analyzer product family — Class II in-vitro diagnostic medical devices for point-of-care whole blood coagulation and platelet function testing. The offering includes benchtop analyzers (SC1, SCP1, SCP2), proprietary disposable test kits (kACT, gbACT, gbACT+, H-gbACT+, aiACT, SonACT, Non-Activated), companion data software (SonoView, Signature Viewer), quality control kits, and accessories. Customers are hospitals, clinical labs, surgical departments, and research institutions requiring hemostasis management and anticoagulation monitoring.

Product overview

Sienco manufactures and distributes the Sonoclot Analyzer product family for whole blood coagulation and platelet function point-of-care testing. The product line consists of three analyzer models (SC1, SCP1, SCP2) that differ in channel count and platelet function capabilities, paired with proprietary data management software (SonoView and Signature Viewer). The system uses disposable test kits including kACT, gbACT, gbACT+, H-gbACT+, aiACT, SonACT, and Non-Activated varieties to detect poor factor performance, low fibrinogen, residual heparin, platelet dysfunction, and hyperfibrinolysis. Supporting products include quality control kits (Reference Viscosity Oil and Reference Plasma) and accessories (SonOil, Probe Extractor, Blunt Cannula Tips). The analyzers are used in cardiovascular surgery, liver transplant, vascular surgery, orthopedic surgery, obstetrics, and hemostasis research applications.

Differentiator

Problem solved

Functional benefit

Brands

• Sonoclot: Sonoclot Coagulation & Platelet Function Analyzer product line including SC1, SCP1, and SCP2 models.
• kACT Kit
• gbACT Kit
• gbACT+ Kit
• H-gbACT+ Kit
• SonACT Kit
• aiACT Kit
• Non-Activated Clotting Test Kit
• SonoView
• Signature Viewer
• SonOil

Products and services

• SC1 Sonoclot Coagulation Analyzer One-channel benchtop in-vitro diagnostic analyzer providing quantitative ACT (Activated Clotting Time) and Clot Rate results for high-dose heparin management. Pairs with SonoView Data Retrieval Software or operates stand-alone. For hospitals and clinical labs performing point-of-care coagulation testing.
• SCP1 Sonoclot Coagulation & Platelet Function Analyzer One-channel analyzer providing quantitative ACT, Clot Rate, and Platelet Function results plus the qualitative Sonoclot Signature. Pairs with Signature Viewer software. For clinical facilities needing platelet function assessment alongside coagulation testing.
• SCP2 Sonoclot Coagulation & Platelet Function Analyzer Two-channel analyzer providing ACT, Clot Rate, and Platelet Function results. Designed for differential testing using gbACT+ and H-gbACT+ test kits. Pairs with Signature Viewer software. For clinical facilities needing parallel or differential hemostasis assessments.
• SonoView Data Retrieval Software Companion software for the SC1 Sonoclot Analyzer that connects a computer to the analyzer via USB to download, sync, and erase stored data, and configure tests available on the analyzer display. Sold in one-copy units.
• Signature Viewer Data Collection Software Companion software for the SCP1 and SCP2 Sonoclot Analyzers that collects serial data from one or more analyzers via USB, stores data in a database, displays the Sonoclot Signature, and supports export in graphic or data formats. Sold in one-copy units.
• kACT Kit Kaolin activated clotting time in-vitro diagnostic test kit for use with Sonoclot Analyzer Systems on native and citrated whole blood. Intended for high-dose heparin management; provides quantitative ACT and Clot Rate results (not for platelet function monitoring). Packaged in 24 or 100 test sizes.
• gbACT Kit Glass bead activated clotting time in-vitro diagnostic test kit for general purpose global hemostasis monitoring at low to moderate heparin levels on native and citrated whole blood. Packaged in 24 or 100 test sizes.
• gbACT+ Kit Glass bead activated clotting time in-vitro diagnostic test kit for Sonoclot Coagulation & Platelet Function Analyzers. Provides quantitative ACT and Clot Rate plus qualitative/quantitative Sonoclot Signature information covering clot detection, fibrin formation, platelet function, and hyperfibrinolysis.
• H-gbACT+ Kit Glass bead activated clotting time test kit with added heparinase capable of neutralizing up to 5 units/ml of heparin. Intended for post-protamine hemostasis monitoring and distinguishing residual heparin effects. Used alongside gbACT+ on the SCP2 analyzer for differential heparinase results.
• aiACT Kit Activated whole blood clotting time in-vitro diagnostic reagent using a proprietary blend of celite and other minerals. Indicated for high-dose heparin anticoagulation management during cardiopulmonary bypass surgery; ACT results substantially unaffected by aprotinin.
• SonACT Kit Celite activated whole blood clotting time in-vitro diagnostic reagent for anticoagulant management up to high heparin levels (0 to approximately 6 units/ml), platelet function assessment, and hyperfibrinolysis screening.
• Non-Activated Clotting Test Kit Foundation test kit for custom-designed hemostasis monitoring using tissue activation, thrombin activation, and other custom activators. Primarily a research tool for monitoring fibrin formation, fibrinolysis, and clot retraction with the Sonoclot Analyzers.
• Reference Viscosity Oil Quality Control Kits Quality control kits for verifying analyzer instrument response. Include Oil QC Fluid, cuvettes, and probes for 24 tests per channel. Available in analyzer-specific versions for DP-2951 (PN 900-1302), SC1/SCP1 (PN 900-1303), and SCP2 (PN 900-1324).
• Reference Plasma Quality Control Kit Quality control kit for verifying correct performance of activated tests. Includes one set of normal and abnormal controls, necessary reagents, and syringes. Recommended monthly use throughout activated test inventory.
• SonOil Light mineral oil accessory used to prevent crust formation on blood clots during Sonoclot analysis. Recommended for tests running over 30 minutes. Supplied as a 20 ml vial (PN 800-0310).
• Probe Extractor Forceps for removing disposable probes after completing a Sonoclot test. One probe extractor is included with each Sonoclot Analyzer (PN 800-0601).
• Blunt Cannula Tips Luer cannula tips that improve control when adding blood to test cuvettes from a syringe (PN 800-0610).

Quantifiable outcome

• Faster and more precise detection of coagulation components compared to conventional viscoelastic or laboratory tests

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Viscell Medical Group (Hong Kong) LimitedcoreChannel Partner/ Reseller/ Distributor · 18 June 2018VMG and Sienco are working closely to address supply chain issues and confusion around valid distribution in China. Primary focus is on providing high quality products and technical support to end users. Sienco warns about multiple fraudulent distributors claiming to have exclusive rights and creating fraudulent authorization documentation.
• Viscell Medical Group (Hong Kong) LimitedcoreChannel Partner/ Reseller/ Distributor · 13 June 2017Sienco appointed Viscell Medical Group (Hong Kong) Limited and its wholly-owned subsidiary Guangzhou Viscell Medical Technology Co., Ltd. (collectively 'VMG') as the exclusive distributor in Mainland China. VMG handles promotion, negotiation, tendering, sales, exhibition, and after-sale service for Sonoclot Analyzer family products including instruments, software, test kits, quality control kits, and accessories. Exclusive authorization commenced June 13, 2017 and is valid through January 31, 2028.
• Getz Healthcare (Hong Kong) Ltd.minorChannel Partner/ Reseller/ DistributorDistributor for Sonoclot products in Hong Kong. Located at Unit 2-3, 11/F, No. 1 Hung To Road, Kwun Tong, Kowloon, HKSAR. Provides local sales and support for Hong Kong market.
• International Medical Intelligence Co., Ltd.minorChannel Partner/ Reseller/ DistributorImporter and distributor of medical equipment for Sonoclot products in Japan. Located in Koshigaya-shi, Saitama, Japan. Handles local regulatory compliance and distribution.
• New-Medical Diagnostics for TradingminorChannel Partner/ Reseller/ DistributorDistributor for Sonoclot products in Egypt. Located in El Mansoura, Dakahila, Egypt. Provides local sales and distribution for Egyptian market.
• Romed N.V.minorChannel Partner/ Reseller/ DistributorDistributor for Sonoclot products in Benelux region (Belgium, Netherlands, Luxembourg). Located in Zoersel, Belgium. Contact: Patrick Rosa.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Haemonetics: Haemonetics is the most direct competitor in viscoelastic coagulation testing through its TEG (Thromboelastography) platform. Both companies sell whole-blood point-of-care analyzers with disposable test cartridges used in cardiovascular surgery, trauma, and critical care, and target overlapping hospital departments and surgical specialties.
• Werfen: Werfen manufactures the ROTEM/ROTEM sigma viscoelastic coagulation analyzers, directly competing with Sonoclot in surgical hemostasis and point-of-care platelet function testing. Both companies target the same surgical and critical-care end markets with proprietary viscoelastic technology and disposable reagent portfolios.
• Diagnostica Stago: Stago is a leading specialty coagulation diagnostics company offering the STA line of lab-based hemostasis analyzers and reagents. While Stago focuses primarily on central lab testing, it competes with Sienco for hospital coagulation testing budgets and offers viscoelastic-adjacent solutions.

Broad incumbents

• Abbott: Abbott is a broad IVD incumbent with significant presence in coagulation and point-of-care diagnostics through its i-STAT and central lab platforms. While not specialized in viscoelastic testing, Abbott competes for the same hospital budgets and represents the type of large-scale competitor that can erode niche players' positions.
• Siemens Healthineers: Siemens Healthineers offers a broad coagulation diagnostics portfolio through its central lab analyzers and reagents, competing for hospital hemostasis testing workloads. As a diversified diagnostics major, it represents the broader competitive set Sienco encounters in hospital procurement decisions.
• Roche Diagnostics: Roche Diagnostics is a global IVD leader with coagulation testing capabilities across its cobas central lab platform. While not specialized in viscoelastic testing, Roche competes in the broader hospital hemostasis diagnostics market that Sienco serves.
• Sysmex: Sysmex is a leading hematology and coagulation diagnostics company offering automated hematology analyzers and coagulation testing systems. While focused on central lab testing, Sysmex competes for hospital hemostasis testing budgets and has global commercial reach comparable to broader IVD players.
• Bio-Rad Laboratories: Bio-Rad offers a portfolio of quality control products and laboratory testing solutions that overlap with Sienco's QC kit offerings. While not a direct viscoelastic testing competitor, Bio-Rad serves the same hospital and clinical laboratory customers with adjacent diagnostic and QC products.

Emerging players

• HemoSonics: HemoSonics developed the Quantra Hemostasis Analyzer, a next-generation point-of-care viscoelastic testing system targeting cardiac surgery and other surgical applications. As a focused emerging player with overlapping use cases, it represents direct emerging competition to Sonoclot in point-of-care surgical hemostasis.
• Entegrion: Entegrion is a specialty hemostasis-focused company developing point-of-care coagulation diagnostics and blood product management solutions for surgical and trauma settings. As a smaller niche player in hemostasis, it represents an emerging competitor in the same targeted clinical use cases as Sonoclot.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sienco